![Apovia](/news-release/logo/214616/0/214616.gif?lastModified=12%2F13%2F2016%2010%3A38%3A43&size=2)
Apovia Initiates MalariVax Phase I Clinical Trials; Clinical Trials for Malaria Vaccine Start at the University of Maryland and in South Wales, U.K.
September 16, 2002 03:28 ET
|
Apovia
MARTINSRIED, Germany and SAN DIEGO, Sept. 16, 2002 (PRIMEZONE) -- Apovia AG and its wholly owned subsidiary Apovia Inc. today announced the initiation of its first human Phase I clinical trials for...
![Apovia](/news-release/logo/214616/0/214616.gif?lastModified=12%2F13%2F2016%2010%3A38%3A43&size=2)
Apovia Raises Euro 19 Million in Private Financing Round
April 22, 2002 01:26 ET
|
Apovia
MARTINSRIED, Germany, April 22, 2002 (PRIMEZONE) -- Apovia AG, the biopharmaceutical company focused on the prevention and treatment of infectious diseases through vaccines, today announced the...